Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: A randomized, placebo-controlled trial

Journal of Clinical Psychiatry

Volumn 73, Issue 1, 2012, Pages 66-73

  Barber, Jacques P ^a,b,d   Barrett, Marna S ^a   Gallop, Robert ^a   Rynn, Moira A ^c   Rickels, Karl ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^d ADELPHI UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; METHYLPHENIDATE; OXYCODONE; PARACETAMOL; PLACEBO; SERTRALINE; VENLAFAXINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HAMILTON SCALE; HUMAN; INCOME; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SUICIDE ATTEMPT; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 84856303564     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.11m06831     Document Type: Article

References (46)

1. Leichsenring F, Rabung S, Leibing E. The efficacy of short-term psychodynamic psychotherapy in specific psychiatric disorders: a meta-analysis. Arch Gen Psychiatry. 2004;61(12):1208-1216. doi:10.101/archpsyc.61.12.1208 PubMed (Pubitemid 39602837)
2. Thompson LW, Gallagher D, Breckenridge JS. Comparative effectiveness of psychotherapies for depressed elders. J Consult Clin Psychol. 1987; 55(3):385-390. doi:10.1037/02-06X.5.3.385 PubMed
3. Shapiro DA, Barkham M, Rees A, et al. Effects of treatment duration and severity of depression on the effectiveness of cognitive-behavioral and psychodynamic-interpersonal psychotherapy. J Consult Clin Psychol. 1994;62(3):522-534. doi:10.1037/02-06X.62.3.52 PubMed
4. Cooper PJ, Murray L, Wilson A, et al. Controlled trial of the short- and long-term effect of psychological treatment of post-partum depression, 1: impact on maternal mood. Br J Psychiatry. 2003;182(5):412-419. doi:10.192/bjp.182.5. 412 PubMed (Pubitemid 36560977)
5. Maina G, Forner F, Bogetto F. Randomized controlled trial comparing brief dynamic and supportive therapy with waiting list condition in minor depressive disorders. Psychother Psychosom. 2005;74(1):43-50. doi:10.159/082026 PubMed (Pubitemid 40091418)
6. Salminen JK, Karlsson H, Hietala J, et al. Short-term psychodynamic psychotherapy and fluoxetine in major depressive disorder: a randomized comparative study. Psychother Psychosom. 2008;77(6):351-357. doi:10.159/015138 PubMed
7. Norcross JC, Karg RS, Prochaska JO. Clinical psychologists in the 1990s: part 1. Clin Psychol. 1997;50 (2):4-9.
8. Leichsenring F, Leibing E. Supportive-Expressive (SE) Psychotherapy: an update. Curr Psychiatry Rev. 2007;3(1):57-64. doi:10.2174/1573407981565 (Pubitemid 46592807)
9. Elkin I, Gibbons RD, Shea MT, et al. Initial severity and differential treatment outcome in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. J Consult Clin Psychol. 1995; 63(5):841-847. doi:10.1037/02-06X.63.5.841 PubMed
10. NIH Policy and Guidelines on the Inclusion of Women and Minorities as Subjects in Clinical Research-Amended, October 2001. Available at: http://grants.nih.gov/grants/funding/women-min/guidelines- amended-10-2001.htm.
11. Insel TR. Translating scientific opportunity into public health impact: a strategic plan for research on mental illness. Arch Gen Psychiatry. 2009;66(2):128-133. doi:10.101/archgenpsychiatry.208.540 PubMed
12. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
13. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-P, version 2.0). New York, NY: New York State Psychiatric Institute Biometrics Research Department; 1995.
14. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56-62. doi:10.136/jnp.23.1.56 PubMed
15. Williams JBW. A structured interview guide for the Hamilton Depression Rating Scale. Arch Gen Psychiatry. 1988;45(8):742-747. PubMed
16. Wei LJ. An application of an urn model to the design of sequential controlled clinical trials. J Am Stat Assoc. 1978;73(363):559-563.
17. Wei LJ, Lachin JM. Properties of the urn randomization in clinical trials. Control Clin Trials. 1988;9(4):345-364. doi:10.1016/0197-2456(8)9048-7 PubMed (Pubitemid 19012638)
18. Diggle P, Liang K, Zeger S. Analysis of Longitudinal Data. New York, NY: Oxford University Press; 1994.
19. Gibbons RD, Hedeker DR, Elkin I, et al. Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH treatment of Depression Collaborative Research Program dataset. Arch Gen Psychiatry. 1993;50(9):739-750. PubMed
20. Frank E, Prien RF, Jarrett RB, et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder: remission, recovery, relapse, and recurrence. Arch Gen Psychiatry. 1991;48(9): 851-855. PubMed
21. Luborsky L. Principles of Psychoanalytic Psychotherapy: Manual for Supportive-Expressive Treatment. New York, NY: Basic Books Inc Publishers; 1984.
22. Luborsky L, Mark D, Hole AV, et al. Supportive-expressive dynamic psychotherapy of depression: a time-limited version. In: Barber JP, Crits-Christoph P, eds. Psychodynamic Psychotherapies for Psychiatric Disorders (Axis I). New York, NY: Basic Books; 1995:13-42.
23. Crits-Christoph P, Cooper A, Luborsky L. The accuracy of therapists'interpretations and the outcome of dynamic psychotherapy. J Consult Clin Psychol. 1988;56(4):490-495. doi:10.1037/02-06X.56.4.490 PubMed
24. Barber JP, Crits-Christoph P, Luborsky L. Effects of therapist adherence and competence on patient outcome in brief dynamic therapy. J Consult Clin Psychol. 1996;64(3):619-622. doi:10.1037/02-06X.64.3.619 PubMed (Pubitemid 26230558)
25. Fawcett J, Epstein P, Fiester SJ, et al; NIMH Treatment of Depression Collaborative Research Program. Clinical management - imipramine/ placebo administration manual. Psychopharmacol Bull. 1987;23(2): 309-324. PubMed
26. Stokes ME, Davis CS, Koch GG, et al. Categorical Data Analysis Using the SAS System. Cary, NC: SAS Institute Inc; 1995.
27. Hedeker D, Gibbons RD. Application of random-effects pattern-mixture models for missing data in longitudinal studies. Psychol Methods. 1997; 2(1):64-78. doi:10.1037/1082-989X.2.1.64 (Pubitemid 127453671)
28. Hamer RM, Simpson PM. Last observation carried forward versus mixed models in the analysis of psychiatric clinical trials. Am J Psychiatry. 2009; 166(6):639-641. doi:10.176/api.ajp.209.09040458 PubMed
29. Shao J, Zhong B. Last observation carry-forward and last observation analysis. Stat Med. 2003;22(15):2429-2441. doi:10.102/sim.1519 PubMed (Pubitemid 36949664)
30. SAS/STAT: User's Guide, Release 6.03. Cary, NC: SAS Institute Inc; 1988.
31. Otto MW, Nierenberg AA. Assay sensitivity, failed clinical trials, and the conduct of science. Psychother Psychosom. 2002;71(5):241-243. doi:10.159/064813 PubMed (Pubitemid 35007647)
32. Walsh BT, Seidman SN, Sysko R, et al. Placebo response in studies of major depression: variable, substantial, and growing. JAMA. 2002; 287(14):1840-1847. doi:10.101/jama.287.14.1840 PubMed (Pubitemid 34303629)
33. Trivedi MH, Rush AJ, Wisniewski SR, et al; STAR*D Study Team. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006;163(1):28-40. doi:10.176/api.ajp.163.1.28 PubMed
34. Humphreys K, Weingardt KR, Harris AHS. Influence of subject eligibility criteria on compliance with National Institutes of Health guidelines for inclusion of women, minorities, and children in treatment research. Alcohol Clin Exp Res. 2007;31(6):988-995. doi:10.1/j.1530-027.207.0391.x PubMed (Pubitemid 46776177)
35. Turner EH, Matthews AM, Linardatos E, et al. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med. 2008;358(3):252-260. doi:10.1056/NEJMsa06579 PubMed
36. Brown C, Schulberg HC, Sacco D, et al. Effectiveness of treatments for major depression in primary medical care practice: a post hoc analysis of outcomes for African American and white patients. J Affect Disord. 1999;53(2):185-192. doi:10.1016/S0165-0327(98)0120-7 PubMed (Pubitemid 29232359)
37. Boyd-Franklin N. Black Families in Therapy: Understanding the African American Experience. New York, NY: Guilford Publications; 2003.
38. Elkin I, Shea MT, Watkins JT, et al. National Institute of Mental Health Treatment of Depression Collaborative Research Program. General effectiveness of treatments. Arch Gen Psychiatry. 1989;46(11):971-982, discussion 983. PubMed
39. DeRubeis RJ, Hollon SD, Amsterdam JD, et al. Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch Gen Psychiatry. 2005;62(4):409-416. doi:10.101/archpsyc.62.4.409 PubMed (Pubitemid 40471690)
40. Dimidjian S, Hollon SD, Dobson KS, et al. Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. J Consult Clin Psychol. 2006;74(4):658-670. doi:10.1037/02-06X.74.4.658 PubMed (Pubitemid 44199118)
41. Jarrett RB, Schaffer M, McIntire D, et al. Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial. Arch Gen Psychiatry. 1999;56(5):431-437. doi:10.101/archpsyc.56.5.431 PubMed (Pubitemid 29215432)
42. Mynors-Wallis LM, Gath DH, Lloyd-Thomas AR, et al. Randomised controlled trial comparing problem solving treatment with amitriptyline and placebo for major depression in primary care. BMJ. 1995;310(6977): 441-445. PubMed
43. Warden D, Trivedi MH, Wisniewski SR, et al. Predictors of attrition during initial (citalopram) treatment for depression: a STAR*D report. Am J Psychiatry. 2007;164(8):1189-1197. doi:10.176/api.ajp.207.0607125 PubMed (Pubitemid 47292407)
44. Kraemer HC, Mintz J, Noda A, et al. Caution regarding the use of pilot studies to guide power calculations for study proposals. Arch Gen Psychiatry. 2006;63(5):484-489. doi:10.101/archpsyc.63.5.484 PubMed
45. Van Voorhis CRW, Morgan BL. Understanding power and rules of thumb for determining sample sizes. Tutorials in Quantitative Methods for Psychology. 2007;3:43-50.
46. Clarke P, Wheaton B. Addressing data sparseness in contextual population research. Sociol Methods Res. 2007;35(3):311-351. doi:10.17/049124106292362